Literature DB >> 17637218

Validity of Asthma Control Test in Chinese patients.

Xin Zhou1, Feng-Ming Ding, Jiang-Tao Lin, Kai-Sheng Yin, Ping Chen, Quan-Ying He, Hua-Hao Shen, Huan-Ying Wan, Chun-Tao Liu, Jing Li, Chang-Zheng Wang.   

Abstract

BACKGROUND: So far, in China, there has been no effective or easy procedure to define the control of asthma. This study assesses the validity of Asthma Control Test in Chinese patients.
METHODS: Three questionnaires (Asthma Control Test, Asthma Control Questionnaire and the 30 second asthma test) were administered to 305 asthma patients from 10 teaching hospitals across China. Spirometry was also used. Asthma specialists rated the control of asthma according to patients' symptoms, medications and forced expiratory volume in first second. The patients were divided into noncontrolled group and controlled group according to the specialists' rating. Reliability, empirical validity and screening accuracy were conducted for Asthma Control Test scores. Screening accuracy was compared among 3 questionnaires. The patients' self rating and the specialists' rating were also compared.
RESULTS: The internal consistency reliability of the 5-item Asthma Control Test was 0.854. The correlation coefficient between Asthma Control Test and the specialists' rating was 0.729, which was higher than other instruments. Asthma Control Test scores discriminated between groups of patients differing in the percent predicted forced expiratory volume in first second (F = 26.06, P < 0.0001), the specialists' rating of asthma control (F = 88.24, P < 0.0001) and the Asthma Control Questionnaire scores (F = 250.57, P < 0.0001). Asthma Control Test showed no significant difference with Asthma Control Questionnaire in the percent correctly classified, while the percent correctly classified by Asthma Control Test was much higher than 30 second asthma test. The patients' self rating was the same as assessment of the specialists (t = 0.65, P = 0.516).
CONCLUSION: The Asthma Control Test is an effective and practicable method for assessing asthma control in China.

Entities:  

Mesh:

Year:  2007        PMID: 17637218

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  Asthma outcomes: composite scores of asthma control.

Authors:  Michelle M Cloutier; Michael Schatz; Mario Castro; Noreen Clark; H William Kelly; Rita Mangione-Smith; James Sheller; Christine Sorkness; Stuart Stoloff; Peter Gergen
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

2.  The validation of the Turkish version of Asthma Control Test.

Authors:  Mehmet Atilla Uysal; Dilsad Mungan; Arzu Yorgancioglu; Fusun Yildiz; Metin Akgun; Bilun Gemicioglu; Haluk Turktas
Journal:  Qual Life Res       Date:  2012-11-10       Impact factor: 4.147

Review 3.  The role of the primary care physician in helping adolescent and adult patients improve asthma control.

Authors:  Barbara P Yawn
Journal:  Mayo Clin Proc       Date:  2011-09       Impact factor: 7.616

4.  Level control of asthma patients in chest specialist clinics.

Authors:  Nasser Al Busaidi; Suad Al Mukhaini
Journal:  Oman Med J       Date:  2009-07

5.  Customized Asthma Control Test with reflection on sociocultural differences.

Authors:  Kwang-Ha Yoo; Jae-Won Jeong; Ho-Joo Yoon; Suk-Il Chang; Hee-Bom Moon; Byoung-Hwui Choi; You-Young Kim; Sang-Heon Cho
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

6.  YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.

Authors:  Tianwen Lai; Min Chen; Zaichun Deng; Yingying L; Dong Wu; Dongming Li; Bin Wu
Journal:  BMC Pulm Med       Date:  2015-01-12       Impact factor: 3.317

Review 7.  Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review.

Authors:  Bas C P van Dijk; Henrik Svedsater; Andreas Heddini; Linda Nelsen; Janita S Balradj; Cathelijne Alleman
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.